Skip to content

FRESH TRACKS THERAPEUTICS, INC.

CIK 0000819050

← back to feed
Revenue (TTM)
$8.49M
+15.3% YoY FY Mar 2024
Net Income (TTM)
−$10.47M
+73.0% YoY FY Mar 2024
EPS Diluted (TTM)
−$3.28
+85.9% YoY FY Mar 2024
Gross Margin
—
FY Mar 2024
Operating Margin
-127.0%
FY Mar 2024
Net Margin
-123.3%
FY Mar 2024
Free Cash Flow (TTM)
−$26.65M
FY Mar 2024
Cash
$10.87M
FY Mar 2024
Total Debt
—
FY Mar 2024
Shares Outstanding
5.97M sh
FY Mar 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings